Search results
MDMA DOA at FDA Advisory Committee
The National Law Review· 14 hours agoAvid readers know we have speculated that the legalization of psychedelics as a prescription medicine was “closer than ever.” Unfortunately, for...
Sarepta Therapeutics surges 36% after-hours following expanded FDA approval
Investing.com via Yahoo Finance· 16 hours agoInvesting.com - Sarepta Therapeutics (NASDAQ:SRPT), a pioneer in precision genetic medicine for rare diseases, surged in Thursday's after-hours deals after receiving extended approval from the ...
US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump
AOL· 12 hours agoThe agency gave traditional approval to patients four years and above who can walk, as well as accelerated approval for those who cannot. The FDA gave accelerated approval ...
...States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for...
Morningstar· 21 hours agoImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy ...
FDA say Dollar Tree did not pull lead-contaminated applesauce from shelves for months
WSOC-TV Charlotte· 1 day agoThe FDA said that it sent out a warning letter to Dollar Tree earlier this month, The Associated...
Palatin initiates Bremelanotide-PDE5i Phase II trial for ED
Clinical Trials Arena via Yahoo Finance· 1 hour agoThe trial aims to enrol around 50 participants for an open-label, dose-escalation study. It will...
Dollar Tree gets FDA warning letter over recalled applesauce pouches
Consumer Affairs· 20 hours agoThe product was pulled from store shelves – but apparently, not all store shelves. The U.S. Food and Drug Administration (FDA) has sent a warning letter to Dollar Tree, telling ...
US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump
Reuters via Yahoo News· 12 hours ago(Reuters) -The U.S. Food and Drug Administration allowed the expanded use of Sarepta Therapeutics'...
US FDA approves expanded use of Sarepta's Duchenne gene therapy
Reuters· 12 hours agoThe agency gave traditional approval to patients four years and above who can walk, as well as...
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 22 hours agoPerhaps most importantly for the FDA, PTC reported no dose-limiting toxicities in the study. Adverse events were similar across treatment and placebo...